Skip to main content

Table 2 Three-year overall survival rates according to patients' N-classification

From: Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases

 

N0

N1

N2

N3

P Value

DFS

93.3

84.9

76.3

73.9

0.07

MFS

93.3

92.2

81.2

73.7

0.007

OS

100

91.2

88

73.9

0.006

  1. Abbreviations: MFS: metastatic-free survival rate; DFS: disease-free survival rate; OS: overall survival rate
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us